Committee reviews S.249 on hospital collaborations and state‑action immunity, asks for more study
Loading...
Summary
Senate Health and Welfare heard an overview of S.249, which would grant state‑action antitrust protection to hospital collaborations that receive AHS authorization and active supervision; members raised questions about federal review, agency capacity, confidentiality, and asked to let the bill "sit" for more analysis.
The Senate Health and Welfare Committee examined S.249 on Feb. 19, a bill proposing a supervised process through the Agency of Human Services (AHS) that would allow certain hospital collaborations to claim state‑action immunity from federal and state antitrust laws if they meet specified approval, supervision and reporting conditions.
Jen Harvey of the Office of Legislative Council told members the bill sets legislative intent that collaborations undertaken for specified purposes — cost containment, improved access to care, quality improvement, preservation of rural/community hospitals and alignment with the state health delivery strategy — may receive state‑action immunity if they meet a multi‑step approval and active supervision process. The bill requires hospitals seeking to explore collaborations to submit an application describing how the activity furthers state health policy goals; the secretary of human services would have 30 days to approve, approve with conditions, or reject a proposal to explore collaboration, and 60 days to review implementation proposals. The secretary may order collaborators to retain a third‑party aggregator or facilitator at the hospital’s expense and may revoke approval if collaborative conduct deviates materially from the application.
The draft allows AHS to keep submitted applications and analyses confidential as presumed proprietary and requires AHS to provide annual, non‑proprietary notice to the Attorney General about approved or revoked collaborations. Committee members pressed staff on whether the state can effectively provide the active supervision that courts require for state‑action immunity; staff said federal case law examines whether supervision is “active” and sufficient, and that courts could still find supervision inadequate, leaving hospitals exposed to litigation.
Members described S.249 as complex and recommended more time for review by AHS, the Attorney General and hospitals to evaluate necessity, agency capacity, the confidentiality carve‑outs, and how the bill would interact with ongoing hospital transformation work. The committee did not take a vote and agreed to let the bill sit for further consideration.
